Metabolic risk score and cancer risk

A new publication from the Me-Can (Metabolic Syndrome and Cancer) project, which is a pooled study of seven European cohorts, shows that high levels of a metabolic risk score is related to an overall increased cancer risk. The highest risk increases were seen for renal cell and liver cancer in men, and for endometrial and pancreatic cancer in women. Professor Tone Bjørge is co-author of the paper.